Literature DB >> 28511424

Mechanism and Immediate Outcome of Significant Mitral Regurgitation Following Balloon Mitral Valvuloplasty with JOMIVA Balloon.

Shanmuga Sundaram1, Tamilarasu Kaliappan1, Rajendiran Gopalan2, Ramasamy Palanimuthu1, Premkrishna Anandhan3, Rinku Mary Joseph4.   

Abstract

INTRODUCTION: Balloon Mitral Valvuloplasty (BMV) with inoue balloon is the most common technique being followed worldwide. Over the wire BMV is a modified technique with Joseph Mitral Valvuloplasty (JOMIVA) balloon and is being followed in certain centres. We hypothesized that, the incidence and mechanism of Mitral Regurgitation (MR) is likely to be different from that of inoue balloon. AIM: To assess the mechanism and immediate clinical outcome of significant MR following BMV with JOMIVA balloon retrospectively.
MATERIALS AND METHODS: We retrospectively analyzed the outcome of 48 patients who developed moderate to severe MR out of 249 patients who underwent BMV in our institute. We analyzed the echocardiographic and clinical parameters of these patients.
RESULTS: Nineteen (7.6%) patients developed severe MR and 29 (11.2%) patients developed moderate MR. Commisural separation resulting in MR was the most common cause which was contributing to 73.6 % and 85.7% of patients with moderate and severe MR respectively. Leaflet tear was the second most common cause which contributed to 15.7% and 14.2% of patients with severe and moderate MR respectively. Chordal rupture contributed to 10.5% of patients with severe MR. Six (31.6%) patients with severe MR developed worsening breathlessness among them one had to be referred for mitral valve replacement during index hospitalization and the rest could be managed medically. Patients with moderate MR remained asymptomatic and stable.
CONCLUSION: Severe MR following JOMIVA BMV results most commonly due to wide separation of commisures. JOMIVA balloon is less likely to cause damage to subvalvular structures than inoue balloon. Most patients who develop severe MR will not require emergency mitral valve replacement. Moderate MR is well tolerated clinically.

Entities:  

Keywords:  Commissural mitral valvuloplasty; Inoue balloon; Vena contracta

Year:  2017        PMID: 28511424      PMCID: PMC5427350          DOI: 10.7860/JCDR/2017/24202.9333

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  14 in total

1.  Natural history and predictors of moderate mitral regurgitation following balloon mitral valvuloplasty using Inoue balloon.

Authors:  K M Krishnamoorthy; S Radhakrishnan; S Shrivastava
Journal:  Int J Cardiol       Date:  2003-01       Impact factor: 4.164

2.  Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography.

Authors:  William A Zoghbi; Maurice Enriquez-Sarano; Elyse Foster; Paul A Grayburn; Carol D Kraft; Robert A Levine; Petros Nihoyannopoulos; Catherine M Otto; Miguel A Quinones; Harry Rakowski; William J Stewart; Alan Waggoner; Neil J Weissman
Journal:  J Am Soc Echocardiogr       Date:  2003-07       Impact factor: 5.251

3.  Long-term clinical and echocardiographic outcome of percutaneous mitral valvuloplasty: randomized comparison of Inoue and double-balloon techniques.

Authors:  D H Kang; S W Park; J K Song; H S Kim; M K Hong; J J Kim; S J Park
Journal:  J Am Coll Cardiol       Date:  2000-01       Impact factor: 24.094

4.  Emergency surgery after percutaneous transmitral commissurotomy: operative versus echocardiographic findings, mechanisms of complications, and outcomes.

Authors:  Praveen Kerala Varma; Sanjay Theodore; Praveen Kumar Neema; Padmakumar Ramachandran; Harikrishnan Sivadasanpillai; Krishna Kumar Nair; Kurur Sankaran Neelakandhan
Journal:  J Thorac Cardiovasc Surg       Date:  2005-09       Impact factor: 5.209

5.  Mitral regurgitation following percutaneous transvenous mitral commissurotomy: a single-center experience.

Authors:  U A Kaul; S Singh; G S Kalra; M Nair; J C Mohan; M Nigam; R Arora
Journal:  J Heart Valve Dis       Date:  2000-03

6.  Which patients benefit from percutaneous mitral balloon valvuloplasty? Prevalvuloplasty and postvalvuloplasty variables that predict long-term outcome.

Authors:  Igor F Palacios; Pedro L Sanchez; Lari C Harrell; Arthur E Weyman; Peter C Block
Journal:  Circulation       Date:  2002-03-26       Impact factor: 29.690

7.  Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation.

Authors:  G T Wilkins; A E Weyman; V M Abascal; P C Block; I F Palacios
Journal:  Br Heart J       Date:  1988-10

8.  Long-term outcomes of significant mitral regurgitation after percutaneous mitral valvuloplasty.

Authors:  Mi-Jeong Kim; Jae-Kwan Song; Jong-Min Song; Duk-Hyun Kang; Young-Hak Kim; Cheol Whan Lee; Myeong-Ki Hong; Jae-Joong Kim; Seong-Wook Park; Seung-Jung Park
Journal:  Circulation       Date:  2006-12-11       Impact factor: 29.690

9.  Temporal trends in percutaneous mitral commissurotomy over a 15-year period.

Authors:  Bernard Iung; Alexane Nicoud-Houel; Olivier Fondard; Tinouch Haghighat; Eric Brochet; Eric Garbarz; Bertrand Cormier; Gabriel Baron; Philippe Luxereau; Alec Vahanian
Journal:  Eur Heart J       Date:  2004-04       Impact factor: 29.983

10.  Percutaneous transatrial mitral commissurotomy by modified technique using a JOMIVA balloon catheter: a cost-effective alternative to the Inoue balloon.

Authors:  Satya N Routray; Trinath K Mishra; Uttam K Patnaik; Mrutyunjay Behera
Journal:  J Heart Valve Dis       Date:  2004-05
View more
  1 in total

1.  Mitral Regurgitation After Percutaneous Mitral Valvuloplasty: Insights Into Mechanisms and Impact on Clinical Outcomes.

Authors:  Maria Carmo P Nunes; Robert A Levine; Renato Braulio; Marcelo A Pascoal-Xavier; Sammy Elmariah; Nayana F A Gomes; Juliana R Soares; William A M Esteves; Xin Zeng; Jacob P Dal-Bianco; Livia S A Passos; Luiz G Passaglia; Victor T Ribeiro; Cláudio L Gelape; Paulo H N Costa; Lucas Lodi-Junqueira; Walderez Dutra; Timothy C Tan; Elena Aikawa; Judy Hung
Journal:  JACC Cardiovasc Imaging       Date:  2020-09-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.